regulus therapeutics inc
(RGLS:NASDAQ SE Consolidated Large Cap)

Executive Profile*

Background*

Dr. Kleanthis G. Xanthopoulos, Ph.D founded Sente, Inc. and serves as its Chief Executive Officer and served as its President. Dr. Xanthopoulos has been the President and Chief Executive Officer of Regulus Therapeutics Inc. since January 2009. He serves as the Managing Director of Life Science Investments at Novera Optics, Inc. He serves as a Member of the Executive Board at BIOCOM, Inc. He served as the President and Chief Executive Officer of Regulus Therapeutics, ... LLC since joining in December 2007. He served as a Vice President and Senior Vice President of Isis Pharmaceuticals, Inc. He joined Regulus in 2007. He served as a Managing Director of Enterprise Partners Venture Capital since June 2006. He co-founded Anadys Pharmaceuticals Inc. in May 2000 and served as its President & Chief Executive Officer until November 2006. From 1997 to 2000, Dr. Xanthopoulos served as Vice President of Genomics & Molecular Biology of Aurora Biosciences Corporation from 1997 to 2000. He participated in The National Institutes of Health Human Genome Project and served as a Section Head of the National Human Genome Research Institute from 1995 to 1997. He has been a Director of Apricus Biosciences, Inc. since November 17, 2011. He serves as a Director of Sente, Inc. He has been a Director of Regulus Therapeutics, LLC since January 2009 and Zosano Pharma, Inc. since April 2013. Dr. Xanthopoulos serves as a Member of the board of directors at Biotechnology Industry Organization (BIO) and Sente, Inc. He serves as an Executive Director of Regulus Therapeutics LLC. He serves as a Director of Apricus Biosciences, Biocom SA and Southern California's Life Science Industry Association. He served as Director of Odyssey Thera, Inc. He served as Director of Anadys Pharmaceuticals Inc. from May 2000 to November 2011. He served as Associate Professor of Molecular Biology at the Karolinska Nobel Medical Institute, Stockholm, Sweden from 1991 to 1995, and Postdoctoral Research Fellow at The Rockefeller University from 1987 to 1990. An Onassis scholar, Dr. Xanthopoulos received B.Sc. in Biology with honors from Aristotle University of Thessaloniki, Greece, and received both his M.Sc. in Microbiology and Ph.D. in Molecular Biology from the University of Stockholm, Sweden.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
RGLS:US	$7.00 USD	0.00

COMPETITOR COMPENSATION